Artificial Cells Nanomedicine and Biotechnology · 2022 · 41 citations · 40 references
PharmacyBiotechnologyOncologyDrug DeliveryNanomaterialsNanoparticle Drug DeliveryCancer NanomedicineGlioblastomaNanomedicineNanoparticle CharacterizationNanoparticle FormulationsNanoparticle SynthesisCancer NanotherapyChitosanChitosan NanocarriersChitosan-based Delivery SystemsChitosan-based NanomaterialsEntrapmentGelationNanoparticles
release study demonstrated sustained release pattern of miR-219 from CS-NPs. Gel retardation assay has confirmed the integrity of miR-219 after production process. The fabricated NPs reduced the survival of U87 MG cells to 78% after 24 h of post-transfection, and into 67.5% after 48 h. However, fibroblasts were not affected by the NPs, revealing their specificity for GBM cells. Given the tumour suppressing function of miR-219, and advantage of CS-NPs for gene delivery to the central nervous system, the presented NPs have a great potential for treatment of GBM.
40
Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Roger Stupp, Warren Mason, Martin J. van den Bent et al. · New England Journal of Medicine · 2005 · 21.6K citations · Full text
Comprehensive genomic characterization defines human glioblastoma genes and core pathways